BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2443569)

  • 1. Serologic cross-reactivity of T11 target structure and lymphocyte function-associated antigen 3. Evidence for structural homology of the sheep and human ligands of CD2.
    Tiefenthaler G; Dustin ML; Springer TA; Hünig T
    J Immunol; 1987 Oct; 139(8):2696-701. PubMed ID: 2443569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosetting of human T lymphocytes with sheep and human erythrocytes. Comparison of human and sheep ligand binding using purified E receptor.
    Selvaraj P; Dustin ML; Mitnacht R; Hünig T; Springer TA; Plunkett ML
    J Immunol; 1987 Oct; 139(8):2690-5. PubMed ID: 3309056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "erythrocyte receptor" of T-lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T-cell activation.
    Hünig T; Tiefenthaler G; Mitnacht R; Köhler C; Lottspeich F; Meuer S
    Behring Inst Mitt; 1987 Jun; (81):31-40. PubMed ID: 2888455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified lymphocyte function-associated antigen-3 and T11 target structure are active in CD2-mediated T cell stimulation.
    Tiefenthaler G; Hünig T; Dustin ML; Springer TA; Meuer SC
    Eur J Immunol; 1987 Dec; 17(12):1847-50. PubMed ID: 2891540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
    Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
    Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. Comparison of the roles of H19 and LFA-3 molecules in T cell activation.
    Groux H; Huet S; Aubrit F; Tran HC; Boumsell L; Bernard A
    J Immunol; 1989 May; 142(9):3013-20. PubMed ID: 2468708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ligand of the erythrocyte receptor of T lymphocytes: expression on white blood cells and possible involvement in T cell activation.
    Hünig TR
    J Immunol; 1986 Mar; 136(6):2103-8. PubMed ID: 2936820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T11TS, the cell surface molecule binding to the "erythrocyte receptor" of T lymphocytes: cellular distribution, purification to homogeneity and biochemical properties.
    Hünig T; Mitnacht R; Tiefenthaler G; Köhler C; Miyasaka M
    Eur J Immunol; 1986 Dec; 16(12):1615-21. PubMed ID: 2880724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified lymphocyte function-associated antigen-3 (LFA-3) activates human thymocytes via the CD2 pathway.
    Denning SM; Dustin ML; Springer TA; Singer KH; Haynes BF
    J Immunol; 1988 Nov; 141(9):2980-5. PubMed ID: 2459236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.
    Selvaraj P; Plunkett ML; Dustin M; Sanders ME; Shaw S; Springer TA
    Nature; 1987 Mar 26-Apr 1; 326(6111):400-3. PubMed ID: 2951597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells.
    Hale LP; Singer KH; Haynes BF
    J Immunol; 1989 Dec; 143(12):3944-8. PubMed ID: 2480381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.
    Hünig T; Tiefenthaler G; Meyer zum Büschenfelde KH; Meuer SC
    Nature; 1987 Mar 19-25; 326(6110):298-301. PubMed ID: 3102975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three different erythrocyte surface molecules are required for spontaneous T cell rosette formation.
    Bernard A; Tran HC; Boumsell L
    J Immunol; 1987 Jul; 139(1):18-23. PubMed ID: 2438349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of the lymphocyte function-associated-2 (LFA-2) molecule.
    Plunkett ML; Springer TA
    J Immunol; 1986 Jun; 136(11):4181-7. PubMed ID: 3517166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte rosettes provide an analogue for Schiff base formation in specific T cell activation.
    Rhodes J
    J Immunol; 1990 Jul; 145(2):463-9. PubMed ID: 2365992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted expression of CD2 among subsets of sheep thymocytes and T lymphocytes.
    Giegerich GW; Hein WR; Miyasaka M; Tiefenthaler G; Hünig T
    Immunology; 1989 Mar; 66(3):354-61. PubMed ID: 2564842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell rosetting is mediated by LFA-3 on autologous erythrocytes.
    Makgoba MW; Shaw S; Gugel EA; Sanders ME
    J Immunol; 1987 Jun; 138(11):3587-9. PubMed ID: 3108368
    [No Abstract]   [Full Text] [Related]  

  • 19. The cell surface molecule recognized by the erythrocyte receptor of T lymphocytes. Identification and partial characterization using a monoclonal antibody.
    Hünig T
    J Exp Med; 1985 Sep; 162(3):890-901. PubMed ID: 2411842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sheep form of leucocyte function antigen-3 (T11TS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor. A new approach to biological response modifier therapy.
    Sarkar S; Begum Z; Dutta S; Dutta SK; Chaudhuri S; Chaudhuri S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):95-106. PubMed ID: 12071536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.